Desferrioxamine Attenuates Doxorubicin-Induced Acute Cardiotoxicity through TFG-beta/Smad p53 Pathway in Rat Model

作者：Al Shabanah Othman A^*; Aleisa Abdulaziz M; Hafez Mohamed M; Al Rejaie Salim S; Al Yahya Abdulaziz A; Bakheet Saleh A; Al Harbi Mohamed M; Sayed Ahmed Mohamed M

来源：Oxidative Medicine and Cellular Longevity, 2012, 2012: 619185.

DOI：10.1155/2012/619185

Interaction of doxorubicin DOX with iron and the consequent generation of reactive oxygen species (ROS) is a major player in DOX-induced cardiomyopathy. Accordingly, this study has been initiated to investigate the preventive effect of the iron chelator, desferrioxamine (DFX), against DOX-induced acute cardiotoxicity in rats. Male Wistar albino rats were divided into four groups and were injected intraperitoneally (I. P.) with normal saline, a single dose of DOX (15 mg/kg), a single dose of DFX (250 mg/kg) and a combined treatment with DFX (250 mg/kg) 30 min prior to a single dose of DOX, (15 mg/kg). A single dose of DOX significantly increased mRNA expression of TGF-beta, Smad2, Smad4, CDKN2A and p53 and significantly decreased Samd7 and Mdm2 mRNA expression levels. Administration of DFX prior to DOX resulted in a complete reversal of DOX-induced alteration in cardiac enzymes and gene expression to normal levels. Data from this study suggest that (1) DOX induces its acute cardiotoxicity secondary to increasing genes expression of TGF-beta/Smad pathway. (2) DOX increases apoptosis through upregulation of CDKN2A and p53 and downregulation of Mdm2 gene expression. (3) The preventive effect of DFX against DOX-induced cardiotoxicity is mediated via the TGF-beta 1/Smad pathway.

• 出版日期2012